期刊书目 › CLINICAL NEUROLOGY(临床神经病学) › ESCI期刊Neuro-Oncology Advances 2024/2025影响因子:3.794 (NEURO-ONCOL ADV) (NULL). (CLINICAL NEUROLOGY)(临床神经病学)Emerging Source

Fresco 发表于 2025-3-23 11:51:30

Submitted on: 02 August 2012.
Revised on: 31 August 2012.
Accepted on: 17 September 2012.
Neuro-Oncology Advances---OXFORD UNIV PRESS

郊外 发表于 2025-3-23 14:24:22

Submitted on: 25 June 2011.
Revised on: 04 August 2011.
Accepted on: 23 August 2011.
NULL

judiciousness 发表于 2025-3-23 19:50:59

Submitted on: 12 October 2012.
Revised on: 22 October 2012.
Accepted on: 05 November 2012.
Neuro-Oncology Advances---OXFORD UNIV PRESS

协议 发表于 2025-3-24 00:58:21

http://reply.papertrans.cn/3/230/22966/22966-14.png

阐释 发表于 2025-3-24 05:16:01

http://reply.papertrans.cn/3/230/22966/22966-15.png

放逐某人 发表于 2025-3-24 06:42:38

http://reply.papertrans.cn/3/230/22966/22966-16.png

meritorious 发表于 2025-3-24 11:30:00

Submitted on: 27 August 2023.
Revised on: 05 October 2023.
Accepted on: 21 October 2023.
NULL

斜 发表于 2025-3-24 18:35:11

Submitted on: 06 June 2019.
Revised on: 10 July 2019.
Accepted on: 03 August 2019.
NULL

adduction 发表于 2025-3-24 21:37:50

Submitted on: 08 July 2018.
Revised on: 15 August 2018.
Accepted on: 10 September 2018.
Neuro-Oncology Advances---OXFORD UNIV PRESS

杠杆 发表于 2025-3-25 02:19:09

http://reply.papertrans.cn/3/230/22966/22966-20.png

查看完整版本: ESCI期刊Neuro-Oncology Advances 2024/2025影响因子:3.794 (NEURO-ONCOL ADV) (NULL). (CLINICAL NEUROLOGY)(临床神经病学)Emerging Source